David James Ballance Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

PHAS Quotes by TradingView

David James Ballance is VP, Research and Sci. Affairs of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 8,519 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2020, when has been sold 919 shares (Common Stock) at a price of $3.0 per share, resulting in proceeds of $2,757. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.52K
0% 3M change
0% 12M change
Total Value Held $0

David James Ballance Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2020
BUY
Grant, award, or other acquisition
$2,757 $3.0 p/Share
919 Added 9.74%
8,519 Common Stock
DJB

David James Ballance

VP, Research and Sci. Affairs
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAS